GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Organics Ltd (NSE:MEDIORG) » Definitions » Notes Receivable

Medicamen Organics (NSE:MEDIORG) Notes Receivable : ₹0.0 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medicamen Organics Notes Receivable?

Medicamen Organics's Notes Receivable for the quarter that ended in Mar. 2024 was ₹0.0 Mil.


Medicamen Organics Notes Receivable Historical Data

The historical data trend for Medicamen Organics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Organics Notes Receivable Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Notes Receivable
- - - -

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24
Notes Receivable - - - - -

Medicamen Organics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Medicamen Organics Notes Receivable Related Terms

Thank you for viewing the detailed overview of Medicamen Organics's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicamen Organics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd is engaged in developing, manufacturing, and distribution of broad range of pharmaceutical dosages including generic dosages in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government and private institutions as contract manufacturer/third party manufacturer. The company markets its product to private pharma companies in domestic as well as international markets through third-party distributors or on a loan license basis.

Medicamen Organics Headlines

No Headlines